Notice2022-04225
Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan; Notification of Proposed Production Activity; Pfizer, Inc. (Nirmatrelvir Active Pharmaceutical Ingredient (API) for COVID-19 Treatment); Kalamazoo, Michigan
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 1, 2022
Issuing agencies
Commerce DepartmentForeign-Trade Zones Board
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 40 (Tuesday, March 1, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 40 (Tuesday, March 1, 2022)]
[Notices]
[Page 11410]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-04225]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-6-2022]
Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan; Notification
of Proposed Production Activity; Pfizer, Inc. (Nirmatrelvir Active
Pharmaceutical Ingredient (API) for COVID-19 Treatment); Kalamazoo,
Michigan
Pfizer, Inc. (Pfizer) submitted a notification of proposed
production activity to the FTZ Board for its facility Kalamazoo,
Michigan. The notification conforming to the requirements of the
Board's regulations (15 CFR 400.22) was received on February 22, 2022.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status materials/components and
specific finished product described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed finished
product and materials/components would be added to the production
authority that the Board previously approved for the operation, as
reflected on the Board's website.
The proposed finished product is Nirmatrelvir API (duty rate,
6.5%).
The proposed foreign-status materials and components include
Registered Starter Chemical PF-04349713-01, Registered Starter Chemical
PF-07321787, Registered Starter Chemical PF-07328614-01, 2-
Hydroxypyridine-N-oxide (HOPO), and Dimethylaminopropylethyl
carbodiimide hydrochloride (EDC HCI) (duty rates are 3.7% or 6.5%). The
request indicates that certain materials/components are subject to
duties under Section 301 of the Trade Act of 1974 (Section 301),
depending on the country of origin. The applicable Section 301
decisions require subject merchandise to be admitted to FTZs in
privileged foreign status (19 CFR 146.41).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
<a href="/cdn-cgi/l/email-protection#1b7d6f615b6f697a7f7e357c746d"><span class="__cf_email__" data-cfemail="cea8bab48ebabcafaaabe0a9a1b8">[email protected]</span></a>. The closing period for their receipt is April 11, 2022.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Diane Finver at
<a href="/cdn-cgi/l/email-protection#0a4e636b646f244c63647c6f784a7e786b6e6f246d657c"><span class="__cf_email__" data-cfemail="a3e7cac2cdc68de5cacdd5c6d1e3d7d1c2c7c68dc4ccd5">[email protected]</span></a>.
Dated: February 23, 2022.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2022-04225 Filed 2-28-22; 8:45 am]
BILLING CODE 3510-DS-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 1, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.